HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $535,645 | -14.2% | 4,630 | -23.7% | 0.02% | -11.8% |
| Q2 2023 | $624,094 | -30.2% | 6,068 | -25.9% | 0.02% | -34.6% |
| Q1 2023 | $893,966 | -28.2% | 8,191 | -25.1% | 0.03% | -31.6% |
| Q4 2022 | $1,245,313 | -20.4% | 10,943 | -56.7% | 0.04% | -29.6% |
| Q3 2022 | $1,564,000 | -41.8% | 25,280 | -24.9% | 0.05% | -39.3% |
| Q2 2022 | $2,686,000 | -36.1% | 33,679 | -15.7% | 0.09% | -25.8% |
| Q1 2022 | $4,204,000 | +2.5% | 39,965 | +5.0% | 0.12% | +3.4% |
| Q4 2021 | $4,100,000 | +1.8% | 38,044 | +3.5% | 0.12% | -19.4% |
| Q3 2021 | $4,028,000 | +27.3% | 36,770 | +8.9% | 0.14% | +25.2% |
| Q2 2021 | $3,163,000 | +31.0% | 33,772 | +28.7% | 0.12% | +22.3% |
| Q1 2021 | $2,415,000 | +1157.8% | 26,242 | +901.2% | 0.09% | +1075.0% |
| Q4 2020 | $192,000 | -5.4% | 2,621 | +0.4% | 0.01% | -11.1% |
| Q3 2020 | $203,000 | -18.1% | 2,611 | -41.5% | 0.01% | -25.0% |
| Q2 2020 | $248,000 | +3000.0% | 4,461 | +1642.6% | 0.01% | – |
| Q1 2020 | $8,000 | -11.1% | 256 | +8.5% | 0.00% | – |
| Q4 2019 | $9,000 | +28.6% | 236 | -11.3% | 0.00% | – |
| Q3 2019 | $7,000 | – | 266 | +638.9% | 0.00% | – |
| Q2 2019 | $0 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |